H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.35 SGD
Market Cap: 108.2m SGD

Intrinsic Value

The intrinsic value of one 1J5 stock under the Base Case scenario is 0.53 SGD. Compared to the current market price of 0.35 SGD, Hyphens Pharma International Ltd is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

1J5 Intrinsic Value
0.53 SGD
Undervaluation 34%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hyphens Pharma International Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about 1J5?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 1J5 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hyphens Pharma International Ltd.

Explain Valuation
Compare 1J5 to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 1J5?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hyphens Pharma International Ltd

Current Assets 92.8m
Cash & Short-Term Investments 19.8m
Receivables 43.4m
Other Current Assets 29.6m
Non-Current Assets 28.6m
PP&E 4.2m
Intangibles 24.3m
Other Non-Current Assets 123k
Current Liabilities 51.5m
Accounts Payable 38.3m
Other Current Liabilities 13.2m
Non-Current Liabilities 4.7m
Long-Term Debt 1.3m
Other Non-Current Liabilities 3.4m
Efficiency

Free Cash Flow Analysis
Hyphens Pharma International Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hyphens Pharma International Ltd

Revenue
185.3m SGD
Cost of Revenue
-115.3m SGD
Gross Profit
70m SGD
Operating Expenses
-56m SGD
Operating Income
14m SGD
Other Expenses
-7.6m SGD
Net Income
6.5m SGD
Fundamental Scores

1J5 Profitability Score
Profitability Due Diligence

Hyphens Pharma International Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Positive ROIC
Healthy Gross Margin
Positive 3Y Average ROE
52/100
Profitability
Score

Hyphens Pharma International Ltd's profitability score is 52/100. The higher the profitability score, the more profitable the company is.

1J5 Solvency Score
Solvency Due Diligence

Hyphens Pharma International Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

84/100
Solvency
Score

Hyphens Pharma International Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

1J5 Price Targets Summary
Hyphens Pharma International Ltd

Wall Street analysts forecast 1J5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1J5 is 0.42 SGD with a low forecast of 0.4 SGD and a high forecast of 0.45 SGD.

Lowest
Price Target
0.4 SGD
15% Upside
Average
Price Target
0.42 SGD
21% Upside
Highest
Price Target
0.45 SGD
29% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 1J5 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one 1J5 stock?

The intrinsic value of one 1J5 stock under the Base Case scenario is 0.53 SGD.

Is 1J5 stock undervalued or overvalued?

Compared to the current market price of 0.35 SGD, Hyphens Pharma International Ltd is Undervalued by 34%.

Back to Top